Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page
- Check6 days agoChange DetectedUpdates added on 2026-02-06, 2026-02-14, and 2026-02-17 reflect new timestamps on the study page, while earlier timestamps 2025-08-08, 2026-02-04, and 2026-02-05 were removed. No substantive study content appears to have changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoChange DetectedPage shows a new revision (v3.4.2) with update dates around 2026-02-04 and 2026-02-05; the previously displayed funding-lapse notice has been removed. No study data or core content changes were made.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding lapse notice and an open-status update for the NIH Clinical Center, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated study-page metadata (Last Update Submitted that Met QC Criteria, Last Update Posted) to reflect current status. Older QC-related labels and update fields were removed and the revision was updated to v3.4.0.SummaryDifference0.2%

- Check35 days agoChange DetectedIPD sharing information, the Informed Consent Form (ICF), the Statistical Analysis Plan (SAP), and the Study Protocol have been removed, along with several drug-related terms and study metadata. These deletions limit access to core study documentation and data-sharing details.SummaryDifference22%

- Check42 days agoChange DetectedAdded a new site revision (v3.3.4) on 2026-01-08. Prior revision entries (v3.3.3) dated 2025-12-23 and 2025-12-24 were removed.SummaryDifference0.2%

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.